Moberg Pharma
Pharmaceutical company developing and commercializing treatments for nail fungus.
MOB | ST
Overview
Corporate Details
- ISIN(s):
- SE0011311596 (+3 more)
- LEI:
- 549300XFXK7DVGDRP410
- Country:
- Sweden
- Address:
- Gustavslundsvagen 42, 167 51 Stockholm
- Website:
- https://www.mobergpharma.com/
- Sector:
- Manufacturing
Description
Moberg Pharma is a pharmaceutical company that develops and commercializes proprietary medical products, focusing on innovative drug delivery of proven compounds. The company's primary asset is MOB-015, a topical formulation for the treatment of onychomycosis (nail fungus). MOB-015 has demonstrated high fungal cure rates in Phase 3 clinical trials and has received market approval in multiple European countries. It is commercialized under the brand name Terclara® in Sweden and Norway, where it has achieved market leadership. Moberg Pharma's business model aims for lower development risk and faster market entry than traditional pharmaceutical development. The company's strategic goal is to establish MOB-015 as the leading global treatment for nail fungus.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-28 08:00 |
New number of shares and votes in Moberg Pharma AB (publ)
|
English | PDF • 147.3 KB | ||
| 2024-06-28 08:00 |
Förändring av antalet aktier och röster i Moberg Pharma AB (publ)
|
Swedish | PDF • 166.9 KB | ||
| 2024-06-24 17:35 |
Moberg Pharma tillförs 336 MSEK genom TO 2 och riktad nyemission till toppgaran…
|
Swedish | PDF • 203.6 KB | ||
| 2024-06-24 17:35 |
Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top g…
|
English | PDF • 185.1 KB | ||
| 2024-06-17 08:00 |
The last day for trading in Moberg Pharma's warrants of series 2023:1 (TO 2) is…
|
English | PDF • 187.0 KB | ||
| 2024-06-17 08:00 |
Sista dag för handel i Moberg Pharmas teckningsoptioner av serie 2023:1 (TO 2) …
|
Swedish | PDF • 193.5 KB | ||
| 2024-06-11 07:30 |
Moberg Pharma has secured exercise of warrants and entered into a top guarantee…
|
English | PDF • 184.2 KB | ||
| 2024-06-11 07:30 |
Moberg Pharma har säkerställt nyttjande av teckningsoptioner och ingått vederla…
|
Swedish | PDF • 209.2 KB | ||
| 2024-06-05 08:00 |
Idag inleds nyttjandeperioden för Moberg Pharmas teckningsoptioner av serie 202…
|
Swedish | PDF • 193.0 KB | ||
| 2024-06-05 08:00 |
The exercise period for Moberg Pharma's warrants of series 2023:1 (TO 2) begins…
|
English | PDF • 168.5 KB | ||
| 2024-05-31 20:00 |
Subscription price for Moberg Pharma's warrants of series 2023:1 (TO 2) determi…
|
English | PDF • 176.4 KB | ||
| 2024-05-31 20:00 |
Teckningskurs fastställd för Moberg Pharmas teckningsoptioner av serie 2023:1 T…
|
Swedish | PDF • 175.3 KB | ||
| 2024-05-22 13:20 | English | PDF • 35.3 KB | |||
| 2024-05-20 12:56 | English | PDF • 35.9 KB | |||
| 2024-05-14 16:30 |
Kommuniké från Moberg Pharmas årsstämma den 14 maj 2024
|
Swedish | PDF • 174.7 KB |
Automate Your Workflow. Get a real-time feed of all Moberg Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Moberg Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Moberg Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-11-11 | Mark Beveridge | Other | Buy | 3,000 | 17,730.00 SEK |
| 2021-11-10 | Mark Beveridge | Other | Buy | 3,000 | 17,310.00 SEK |
| 2021-11-09 | Mark Beveridge | Other | Buy | 5,000 | 29,800.00 SEK |
| 2021-02-10 | Cindy Wong | Other | Buy | 5,000 | 31,675.00 SEK |
| 2021-02-09 | Cindy Wong | Other | Buy | 5,000 | 30,800.00 SEK |
Peer Companies
